A growing body of literature has proved that YWHAZ is overexpressed in a wide range of tumor types, such as lung cancer, breast cancer, colorectal cancer, and HCC (Gan et al., 2020). The gene discussed is YWHAZ; the disease is hepatocellular carcinoma.